Resumen
Surgery is the preferred treatment of choice for early-stage lung cancer, but historically, it required large incisions (open surgery) for access and removal of the tumor. Latest guidelines recommend minimally invasive surgery (MIS) as a preferred option for lung cancer due to better clinical outcomes. However, there is insufficient RCT (randomized clinical trial) evidence to establish the superiority of MIS over open surgery. This study revealed selection bias and problems related to surgical approach, with no significant difference in major postoperative complications between thoracotomy and MIS. Therefore, it is reasonable to allow experienced surgeons to choose the appropriate surgical approach for each patient.